I.V. MADYANOV¹, T.S. MADYANOVA²

¹Postgraduate Doctors’ Training Institute of Healthcare Ministry of Chuvash Republic, Cheboksary

²Aybolit M Medical Center, Cheboksary

Contact details:

Madyanov I.V. ― MD, Professor, Head of the Endocrinology Department

Address: 27 Mikhail Sespel Str., 428018 Cheboksary, е-mail: igo-madyanov@yandex.ru

Objective: to analyze the current publications on menopausal hormonal therapy (MHT) for thyroid diseases, diabetes, and obesity.

Material and methods. A review of the main publications in the modern periodic scientific literature on the topic of the use of MHT for thyroid diseases, diabetes mellitus, and obesity.

Results. The review presents the modern principles of rational MHT for major endocrine diseases.

Conclusions.  Menopausal hormone therapy can be successfully used for thyroid diseases, diabetes mellitus and obesity, taking into account the specific pathology and the choice of rational treatment tactics.

Key words: menopausal hormone therapy, thyroid disease, diabetes mellitus, obesity.

(For citation: Madyanov I.V., Madyanovа T.S. Menopausal hormonal therapy in major endocrine diseases. Practical medicine. 2019. Vol. 17, № 4, P. 118-122)

REFERENCES

1. Menopauzal’naya gormonoterapiya i sokhranenie zdorov’ya zhenshchin zrelogo vozrasta. Klinicheskie rekomendatsii (Protokol lecheniya) [Menopausal hormone therapy and maintaining the health of mature women. Clinical recommendations (treatment protocol)]. Pis’mo Ministerstva zdravookhraneniya RF ot 02.10.2015 g. no. 15-4/10/2-5804.
2. Baber R.J, Panay N., Fenton AYu and the IMS Writing Group NS 2016 IMS Recommendations on women’s midlife health and menopause hormone therapy. Climacteric, 2016, vol. 19, no. 2, pp. 109-150.
3. Madyanov I.V., Madyanova T.S. Menopauzal’naya gormonal’naya terapiya. V pomoshch’ terapevtu i vrachu obshchey praktiki [Menopausal hormone therapy. To help the therapist and general practitioner]. Moscow: GEOTAR-Media, 2018. 160 p.
4. Berketova T.Yu., Ragozin A.K. Features of peri- and postmenopause in women with thyroid diseases. Vestnik reproduktivnogo zdorov’ya, 2009, no. 2, pp. 26-31 (in Russ.).
5. Kakhturiya Yu.B., Kalashnikova M.F., Mel’nichenko G.A. Features of hormone replacement therapy in women with endocrine diseases. Ginekologiya, 2002, no. 1, pp. 35-39 (in Russ.).
6. Pestrikova T.Yu., Yurasova E.A., Yachinskaya T.V. Kovaleva T.D. Menopausal hormone therapy or non-hormonal treatment: a rational choice. Ginekologiya, 2015, no. 3, pp. 34-39 (in Russ.).
7. Deryabina E.G., Bashmakova N.V. The prevalence and structure of thyroidopathies after natural and surgical menopause in women aged 45-55 in a region with mild iodine deficiency. Ural’skiy meditsinskiy zhurnal, 2008, no. 12, pp. 24-27 (in Russ.).
8. Schindler A.E. Thyroid function and postmenopause. Gynecological Enocrinology, 2003, vol. 17, no. 1, pp. 79-85.
9. Kobernik M.Yu., Sandakova E.A., El’kin V.D. Pathological menopause and hypothyroidism as factors in menopausal skin aging. Prakticheskaya meditsina, 2013, vol. 7, no. 76, pp. 140-143 (in Russ.).
10. Gromova V.A., Vorokhobina N.V., Malygina O.F., Kuznetsova A.V. The use of low-dose forms of estrogen-progestogen drugs in women with diffuse-nodular non-toxic goiter and autoimmune thyroiditis. Vestnik Severo-Zapadnogo gosudarstvennogo meditsinskogo universiteta im I.I. Mechnikova, 2015, vol. 7, no. 4, pp. 40-45 (in Russ.).
11. Madyanov I.V., Madyanova T.S., Kichigin V.A. et al. Rezul’taty epidemiologicheskogo poperechnogo issledovaniya po izucheniyu rasprostranennosti patologii shchitovidnoy zhelezy u vzroslykh zhiteley Chuvashii [Results of an epidemiological cross-sectional study to study the prevalence of thyroid pathology in adult residents of Chuvashia]. Voprosy diagnostiki i lecheniya neyroendokriiykh zabolevaniy: sb. nauchnykh trudov. Nizhniy Novgorod: NGMA, 2007. Pp. 78-80.
12. Ceresini G., Milli B, Morganti S. et al. Effect of estrogen therapy for 1 year on thyroid volume and thyroid nodules in post-menopausal women. Menopause, 2008, vol.15, no. 2, rr. 326-331
13. Gromova V.A., Vorokhobina N.V., Malygina O.F., Kuznetsova A.V. The effect of low-dose estrogen-progestogen drugs on bone mineral density in postmenopausal women with diffuse-nodular non-toxic goiter and autoimmune thyroiditis. Vestnik Severo-Zapadnogo gosudarstvennogo meditsinskogo universiteta im. I.I. Mechnikova, 2015, vol. 7, no. 4, pp. 38–43 (in Russ.).
14. Grigoryan O.R. Menopausal syndrome in women with diabetes mellitus. Sakharnyy diabet, 2013, no. 3, pp. 103-108 (in Russ.).
15. Grigoryan O.R., Andreeva E.N., Troshina E.A., Pokusaeva V.N. Ozhirenie i menopauza [Obesity and Menopause]. Ozhirenie u zhenshchin. Moscow: Meditsinskoe informatsionnoe agentstvo, 2017. Pp. 233-268.
16. Schifren J.L., Gass M.L.S. The North American Menopause Society Recommendations for Clinical Care of Midlife Women. Menopause, 2014, vol. 21, no.10, rr. 1038-1062.
17. Rachoń D., Teede H. Ovarian function and obesity — interrelationship, impact on women’s reproductive lifespan and treatment options. Mol. Cell Endocrinol, 2010, vol. 316, no. 2, rr. 172-179.
18. Madyanov I.V., Madyanova T.S. Does menopausal hormone therapy promote weight gain? (according to the recommendations of IMS 2016 on the health of women of mature age and menopausal hormone therapy). Zdravookhranenie Chuvashii, 2017, no. 2, pp. 89-95.
19. Harman S.M., Black D.M., Naftolin F., Brinton E.A., Budoff M.J., Cedars M.I. et al. Arterial imaging outcomes and cardiovascular risk factors in recently menopausal women: a randomized trial. Ann. Intern. Med, 2014, vol. 161, no. 4, rr. 249-260.
20. Tremollieres F., Brincat M., Erel C.T. et al. European Menopause and Andropause Society. EMAS position statement: Managing menopausal women with a personal or family history of VTE. Maturitas, 2011, vol. 69, no. 2, rr. 195-198.
21. Baranova E.I., Bol’shakova O.O., Zazerskaya I.E., Yusipova T.Kh. The effect of replacement therapy with drospirenone on the structural and functional parameters of the cardiovascular system in women with hypertension and abdominal obesity in postmenopausal women. Arterial’naya gipertenziya, 2015, no. 4, pp. 372-377 (in Russ.).
22. Tolstov S.I., Salov I.A., Rebrov A.P. The severity of abdominal obesity and disorders of carbohydrate metabolism in women in early postmenopausal women and the possibility of correction of the revealed disorders. Farmateka, 2017, no. 3, pp. 36-40 (in Russ.).
23. Madyanov I.V. Behavioral types in patients with exogenously constitutional obesity and metabolic syndrome. Zdravookhranenie Chuvashii, 2016, no. 3, pp. 10-14 (in Russ.).